MBRX

Moleculin Biotech (MBRX)

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Details

Daily high

$7.98

Daily low

$7.01

Price at open

$7.46

52 Week High

$91.25

52 Week Low

$6.01

Market cap

15.0M

Dividend yield

0.00%

Volume

794,381

Avg. volume

107,747

P/E ratio

-.12

Moleculin Biotech News